Concomitant synthesis of growth factors and their receptors—an aspect of malignant transformation
- 1 March 1984
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 33 (6) , 941-943
- https://doi.org/10.1016/0006-2952(84)90449-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor.Proceedings of the National Academy of Sciences, 1983
- Simian Sarcoma Virus onc Gene, v- sis , Is Derived from the Gene (or Genes) Encoding a Platelet-Derived Growth FactorScience, 1983
- Cellular responsiveness to growth factors correlates with a cell's ability to express the transformed phenotypeCell, 1983
- Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virusNature, 1983
- Molecular cloning and nucleotide sequence of a transforming gene detected by transfection of chicken B-cell lymphoma DNANature, 1983
- Gastrin and the transforming protein of polyoma virus have evolved from a common ancestorFEBS Letters, 1982
- Platelet-derived growth-factor requirements for in vitro proliferation of normal and malignant mesenchymal cellsBritish Journal of Cancer, 1981
- Autocrine Secretion and Malignant Transformation of CellsNew England Journal of Medicine, 1980
- Role of serum components in density-dependent inhibition of growth of cells in culture. Platelet-derived growth factor is the major serum determinant of saturation densityThe Journal of cell biology, 1980
- Transforming viruses directly reduce the cellular growth requirement for a platelet derived growth factorJournal of Cellular Physiology, 1978